Order Article Reprints

López-Díaz de Cerio A, Perez-Estenaga I, Inoges S, Abizanda G, Gavira JJ, Larequi E, Andreu E, Rodriguez S, Gil AG, Crisostomo V, et al. Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics. 2021; 13(8):1269. https://doi.org/10.3390/pharmaceutics13081269

López-Díaz de Cerio, Ascensión, Iñigo Perez-Estenaga, Susana Inoges, Gloria Abizanda, Juan José Gavira, Eduardo Larequi, Enrique Andreu, Saray Rodriguez, Ana Gloria Gil, Verónica Crisostomo, and et al. 2021. "Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy" Pharmaceutics 13, no. 8: 1269. https://doi.org/10.3390/pharmaceutics13081269

López-Díaz de Cerio, A., Perez-Estenaga, I., Inoges, S., Abizanda, G., Gavira, J. J., Larequi, E., Andreu, E., Rodriguez, S., Gil, A. G., Crisostomo, V., Sanchez-Margallo, F. M., Bermejo, J., Jauregui, B., Quintana, L., Fernández-Avilés, F., Pelacho, B., & Prósper, F. (2021). Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics, 13(8), 1269. https://doi.org/10.3390/pharmaceutics13081269